Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for healthcare professionals.
Entries Tagged as '#fdasm'
Paul Roellig of BulletinNEWS on the FDA and Publishing
November 20th, 2009 · No Comments · News
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Robert Winder of VuMedi Talks About HCP Concerns and the FDA’s Social Media Policies
November 19th, 2009 · No Comments · News
Robert Winder, CEO of VuMedi talks about educating Health Care Professionals and how company concerns about FDA Regulations can actually impede information distribution.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Mark Senak Tells the FDA – “the System is Broken!”
November 18th, 2009 · No Comments · News
Mark Senak, SVP of Fleishman-Hillard and author of the EYE ON FDA blog declares “the system is broken” and offers the FDA some advice on how to deal with the media.
Tags:#fdasm·advertising·Blogs·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Pharma·social media·Thought Leaders·Trends
John Kamp of the AAAA at the FDA Hearings on Social Media
November 16th, 2009 · 1 Comment · News
John Kamp of the AAAA’s of the Coalition for Healthcare Communication talks about advertising & social media and how they can help the FDA educate healthcare consumers.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Rohit Bhargava of Ogilvy PR 360 talks PR, the FDA and Social Media
November 13th, 2009 · 2 Comments · News, Uncategorized
Rohit Bhargava of Ogilvy PR 360 presents another unique perspective on social media at the FDA Hearings in Washington.
Tags:#fdasm·branding·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Our EXCLUSIVE Interview with Thomas Abrams at the FDA Hearings
November 13th, 2009 · 3 Comments · News
PIXELS AND PILLS is proud to present our exclusive interview with Thomas Abrams, Director of DDMAC for the FDA. In this revealing conversation, Mr. Abrams talks about the intent behind the FDA hearings on social media and how he feels about the testimony that has been presented at the meetings.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·drug safety·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·technology·Thought Leaders·Trends
What Happened on Day 1 of the FDA Hearings – Our Quick and Easy Summary
November 13th, 2009 · 1 Comment · News
By Kimberley Irish
Interesting information presented at the FDA’s public hearing regarding the promotion of FDA-regulated medical products using the Internet and social media tools.
Day 1, Thursday, November 12: The FDA listened to a parade of pharmaceutical manufacturers, marketers, Internet companies, and nonprofit health advocacy groups. There were many presentations loaded with survey data and many [...]
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Peter Pitts Talks with Pixels and Pills at the FDA Hearings
November 13th, 2009 · 2 Comments · News
Peter Pitts, former FDA staffer and President of the Center for Medicine in the Public Interest provides his unique take on the FDA Hearings on Social Media.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Jack Barrette on Health Activism and the FDA Hearings
November 13th, 2009 · 4 Comments · News
Jack Barrette CEO of WEGO Health discusses Health Activism and his ideas about how the FDA can handle the challenges of Pharma involvement in social media.
Tags:#fdasm·advertising·communication·Communities·Compliance·digital strategy·Digital Tools·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
Jim Sandino and Jillian Tate on Traditional and Social Media at the FDA Hearings
November 13th, 2009 · 2 Comments · News
Jim Sandino and Jillian Tate of Integrated Media Solutions discuss the links between traditional and Social Media and how the FDA needs to understand the complete marketing lifecycles of products.
Tags:#fdasm·advertising·communication·Communities·Compliance·Conferences·digital strategy·Digital Tools·Education·FDA·Legal Issues·marketing·media·Patients·Pharma·Pharmaceutical industry·social media·Thought Leaders·Trends
